Nearly 40% of the North American population suffers from allergy. Experts predict pollencounts to double in the next couple of decades. From simple conjunctivitis to atopic disease,the purpose of this course is to focus on epidemiology, prevalence, and the immunology sideof things with Type 1-4 hypersensitivity

Over 700 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• Very informative speaker! Makes the info easier to understand.

• Thanks for the great CE course!

• it's nice to hear about something we see multiple times a day!

• New interesting topic I enjoyed learning about

• very knowledgeable speaker, good presentation of topics

• Great lecture! A lot was covered, very thorough review.

• Great information for spring allergies

• Great topic! Really enjoyed this presentation!! Thanks for all the cases and great pictures!

• Short and to the point excellent

• Dr. Caldwell is a great lecturer! Keeps topics succinct and interesting.

Speaker: Dr. Gregory Caldwell

This event is COPE approved for 1 hour of live continuing education.

Thank you to Ocular Therapeutics for supporting this event with an unrestricted educational grant.